NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cue Biopharma (CUE)

Technical Analysis Report for USA stock CUE Cue Biopharma. Dated: 18 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma

Cue Biopharma Opened at 27.39 and Closed at: 25.70, which is -7.55% of previous session's close. It moved within a range of 24.31 and 27.95
The session was a Bearish session with an average volume of 270200, which is -12.95% of previous session's volumes.

• Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Dead cross was found 9 days back on mid term averages

Support for tomorrow is 23.19 and resistance for tomorrow is 26.83
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 24.02, 22.35 resistance for tomorrow's hourly charts is 27.66, 29.63

10 Day SMA for Cue Biopharma (CUE) is 28.42 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Cue Biopharma (CUE) is 29.16 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Cue Biopharma (CUE) is 29.48 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 22.87 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Cue Biopharma is 11.64 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Cue Biopharma is at 29.16 and 200 DMA is at 11.64, while 50 DMA and 100 DMA are at 29.48 and 22.87 respectively

Cue Biopharma (CUE) moving average of 20 SMA is at 29.16 and 20 EMA is at 29.07

Cue Biopharma (CUE) moving average of 50 SMA is at 29.48 and 50 EMA is at 27.98

Cue Biopharma (CUE) moving average of 100 SMA is at 22.87 and 100 EMA is at 23.18

Cue Biopharma (CUE) moving average of 200 SMA is at 11.64 and 200 EMA is at 16.15

Msa Safety has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Msa Safety, about 31.13% more returns!

Inspire Medical has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Inspire Medical, about 35.26% more returns!

Cvs Health has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Cvs Health, about 11.12% more returns!

Tonix Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Tonix Pharmaceuticals, about 41.54% more returns!

Bio Techne has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Bio Techne, about 22.96% more returns!

Savara Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Savara Inc, about 15.72% more returns!

Spero Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Spero Therapeutics, about 24.89% more returns!

Regeneron Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Regeneron Pharmaceuticals, about 46.62% more returns!

Phio Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 19.55% more returns!

Neogenomics Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Neogenomics Inc, about 33.99% more returns!

Lemaitre Vascular has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 5.95% more returns!

Aurinia Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 22.72% more returns!

Assembly Biosciences has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Assembly Biosciences, about 49.73% more returns!

Argenx Se has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Argenx Se, about 29.73% more returns!

Align Technology has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Align Technology, about 22.13% more returns!

Ac Immune has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Ac Immune, about 37.06% more returns!

Cue Biopharma Technical analysis of indicators

Price action analysis of Cue Biopharma (CUE) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a SELL signal for Cue Biopharma in short term but the sell signal is initial and weak.

Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Cue Biopharma in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Cue Biopharma is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 28.27 and Cue Biopharma CUE stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.

Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CUE Experts View which covers a lot of information including buying and selling signals

CUE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet